Home > Healthcare > Medical Devices > Diagnostic Devices > Immunohematology Market

Immunohematology Market Size

  • Report ID: GMI1652
  • Published Date: Jul 2021
  • Report Format: PDF

Immunohematology Market Size

Immunohematology Market size exceeded USD 2.3 billion in 2020 and is predicted to grow at 4% CAGR between 2021 and 2027. Market growth is attributed to the rising awareness surrounding blood donation. Several private and public entities as well as NGOs are noted to organize awareness campaigns for importance of blood donation as well as safe blood and blood products. Also, immunohematology technologies enable the detection of blood associated diseases and infections, thus fundamentally transforming the market space.


Immunohematology Market Overview

To understand key trends  
Download Free Sample

The COVID-19 pandemic has disrupted all healthcare services including blood transfusion, storage as well as similar blood component services. At the onset of coronavirus, the research fraternity stated that transmission of COVID-19 infection via blood transfusion is only theorical and highly minimal. It is also noted that owing to the pandemic, governments as well as healthcare associations have implemented various regulations and guidelines to limit the spread of infection among healthcare practitioners.


While elective surgeries and non-urgent clinical interventions were deferred as a measure to optimise healthcare facilities for the treatment of COVID-19 patients, the demand for blood also plummeted. On the upside, the U.S. Food and Drug Administration (FDA) sanctioned emergency authorization of convalescent plasma therapy for the treatment of COVID-19 illness. The blood from recovered patients is studied to contain plasma and antibodies which boosts the infected patients’ immune system leading to a speedy recovery. With signs of hesitation being reported from several developing and under-developed countries, the blood transfusion services reported a sluggish growth and the market expanded in tandem with it. However, as consumers gain clarity surrounding plasma therapy and blood donation services, the market is anticipated to gain traction in the coming years.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size surpassed USD 2.4 billion in 2020 and will grow at a CAGR of 4% from 2021 to 2027.

Reagents recorded a revenue of over USD 1.5 billion in 2020 and will grow owing to their wide range of uses including the determination of group and Rh phenotype, analysis of the ABO system, and the identification of infrequent antibodies.

Polymerase chain reaction (PCR) registered a revenue of USD 857.9 million in 2020 and will depict appreciable growth driven by the increasing number of serological tests and the rising prevalence of hematological disorders.

The North America market will grow at a rate of 3.7% between 2021 and 2027 propelled by the high prevalence of leukemia in the region.

Immunohematology Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2020
  • Companies covered: 13
  • Tables & Figures: 194
  • Countries covered: 18
  • Pages: 150
 Download Free Sample